BRAIN Biotech AG
Develops enzymes and microorganisms for the food, chemical, and life sciences sectors.
BNN | F
Overview
Corporate Details
- ISIN(s):
- DE0005203947 (+1 more)
- LEI:
- 391200JKPVHLD6JLZ107
- Country:
- Germany
- Address:
- Darmstädter Straße 34-36, 64673 Zwingenberg
- Website:
- https://www.brain-biotech.com/
Description
BRAIN Biotech AG is an industrial biotechnology company specializing in the discovery, development, and production of specialty enzymes, high-performance microorganisms, and bioactive compounds. The company provides tailor-made biosolutions and contract research and development (R&D) services to partners in the food, chemical, and life sciences sectors. Core competencies include enzyme technology, microbial strain development, and bioprocess development. By leveraging an advanced technology portfolio, which includes proprietary platforms for enzyme discovery and genome editing, the company enables its partners to create more sustainable and efficient industrial products and processes, contributing to the bioeconomy.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2025-01-17 00:00 |
Annual financial report 2023/2024
|
English | PDF • 3.0 MB | ||
| 2025-01-17 00:00 |
Jahresfinanzbericht 2023/2024
|
German | PDF • 3.0 MB | ||
| 2025-01-16 11:26 |
BRAIN Biotech AG: Adriaan Moelker, buy
|
English | HTML • 8.5 KB | ||
| 2025-01-16 07:30 |
Annual Report 2023/24: BRAIN Biotech AG acts from a strong cash position and is…
|
English | HTML • 23.7 KB | ||
| 2025-01-15 07:30 |
Annual Report 2023/24: BRAIN Biotech AG acts from a strong cash position and is…
|
English | HTML • 23.7 KB | ||
| 2025-01-08 16:34 | English | HTML • 4.6 KB | |||
| 2025-01-07 16:34 | English | HTML • 4.6 KB | |||
| 2025-01-07 00:00 |
Hinweis auf Konzernabschluss vom 01.10.2023 bis zum 30.09.2024
|
German | HTML • 5.8 KB | ||
| 2025-01-07 00:00 |
Hinweis auf Jahresfinanzbericht vom 01.10.2023 bis zum 30.09.2024
|
German | HTML • 5.8 KB | ||
| 2024-12-13 09:00 |
BRAIN Biotech AG Sharpens Focus on Profitable Growth
|
English | HTML • 12.2 KB | ||
| 2024-12-12 09:00 |
BRAIN Biotech AG Sharpens Focus on Profitable Growth
|
English | HTML • 12.2 KB | ||
| 2024-10-03 14:00 |
Prof. Dr. Wiltrud Treffenfeldt leaves Supervisory Board of BRAIN Biotech AG for…
|
English | DOC • 9.8 KB | ||
| 2024-09-27 15:13 | German | DOC • 13.6 KB | |||
| 2024-09-20 19:50 |
BRAIN Biotech AG concludes major pharma compound transaction valued up to EUR 1…
|
English | DOC • 14.9 KB | ||
| 2024-09-20 19:47 |
BRAIN Biotech AG concludes royalty monetization deal for up to EUR 128.88 milli…
|
English | DOC • 7.4 KB |
Automate Your Workflow. Get a real-time feed of all BRAIN Biotech AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BRAIN Biotech AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BRAIN Biotech AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-03 | Schneiders, Michael | Board | Buy | None | 25,000.00 EUR |
| 2025-01-16 | Moelker, Adriaan | Board | Buy | None | 35,795.96 EUR |
Peer Companies
